상세 보기
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
- Oh, Hyung-Joo;
- Choi, Yoo-Duk;
- Choi, Yoon-La;
- Park, Ha-Young;
- Yoon, Joon-Young;
- 외 5명
WEB OF SCIENCE
0SCOPUS
0초록
MET exon 14 skipping is an actionable oncogenic driver in non-small cell lung carcinoma (NSCLC); however, noncanonical splice-region variants are frequently classified as variants of unknown significance (VUS), which may result in missed therapeutic opportunities and highlight limitations in current DNA next-generation sequencing (NGS) reporting criteria. We report a patient with pulmonary sarcomatoid carcinoma harboring a noncanonical MET splice donor-proximal indel (c.3022_3028 + 13delinsA), initially interpreted as a VUS, who achieved a rapid and durable response to capmatinib. Subsequent RNA sequencing and droplet digital PCR (ddPCR) confirmed MET exon 14 skipping, supporting the value of orthogonal transcript-level validation for exon-adjacent variants.
키워드
- 제목
- A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
- 저자
- Oh, Hyung-Joo; Choi, Yoo-Duk; Choi, Yoon-La; Park, Ha-Young; Yoon, Joon-Young; Kim, Jang-Hyeon; Lim, Jung-Hwan; Park, Cheol-Kyu; Oh, In-Jae; Kim, Young-Chul
- 발행일
- 2026-08-07
- 유형
- Article
- 저널명
- Thoracic Cancer
- 권
- 17
- 호
- 15
- 언어
- ENG
- 출판사
- WILEY
- 발행국가
- 미국
- ISSN
- E 1759-7714
P 1759-7706